Evaluation of a bioluminescent mouse model expressing aromatase PII-promoter-controlled luciferase as a tool for the study of endocrine disrupting chemicals.
Dysfunction of the enzyme aromatase (CYP19) is associated with endocrine pathologies such as osteoporosis, impaired fertility and development of hormone-dependent cancers. Certain endocrine disrupting chemicals affect aromatase expression and activity in vitro, but little is known about their ability to do so in vivo. We evaluated a bioluminescent mouse model (LPTA®)CD-1-Tg(Cyp19-luc)-Xen) expressing luciferase under control of the gonadal aromatase pII promoter as an in vivo screening tool for chemicals that may affect aromatase expression. We studied the effects of forskolin, pregnant mare serum gonadotropin and atrazine in this model (atrazine was previously shown to induced pII-promoter-driven aromatase expression in H295R human adrenocortical carcinoma cells). About 2-4 out of every group of 10 male or female Cyp19-luc mice injected i.p. with 10 mg/kg forskolin had increased gonadal bioluminescence after 3-5 days compared to controls; the others appeared non-responsive. Similarly, about 4 per group of 9 individual females injected with pregnant mare serum gonadotropin had increased ovarian bioluminescence after 24 h. There was a statistically significant correlation between ovarian bioluminescence and plasma estradiol concentrations (n=14; p=0.022). Males exposed to a single dose of 100 mg/kg or males and females exposed to 5 daily injections of 30 mg/kg atrazine showed no change in gonadal bioluminescence over a 7 day period, but a significant interaction was found between atrazine (100 mg/kg) and time in female mice (p<0.05; two-way ANOVA). Ex vivo luciferase activity in dissected organs was increased by forskolin in testis, epididymis and ovaries. Atrazine (30 mg/kg/day) increased (30%) luciferase activity significantly in epididymis only. In conclusion, certain individual Cyp19-luc mice are highly responsive to aromatase inducers, suggesting this model, with further optimization, may have potential as an in vivo screening tool for environmental contaminants.
Rivest
Patricia
P
INRS-Institut Armand-Frappier, Université du Québec, 531 blv des Prairies, Laval, QC, Canada H7V 1B7. patricia.rivest@iaf.inrs.ca
Devine
Patrick J
PJ
Sanderson
J Thomas
JT
D000818:Animals; D001141:Aromatase / Q000096:biosynthesis* / Q000235:genetics; D052244:Endocrine Disruptors / Q000032:analysis*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D006736:Horses; D006801:Humans; D008156:Luciferases / Q000096:biosynthesis* / Q000235:genetics; D008164:Luminescent Proteins / Q000032:analysis*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D023421:Models, Animal; D010053:Ovary / Q000201:enzymology; D011401:Promoter Regions, Genetic / Q000502:physiology*; D013737:Testis / Q000201:enzymology
D052244:Endocrine Disruptors; D008164:Luminescent Proteins; D008156:Luciferases; D001141:Aromatase